Artboard 11

LISAvienna's September 2024 newsletter is now available

Dive into the latest news and updates from Vienna’s thriving life sciences sector.

Here's a glimpse of what’s covered:

  • Aithyra: New OeAW institute on biological AI founded in Vienna with a €150M investment from Boehringer Ingelheim Stiftung
  • Biomay: Strategic partnership with Areterna to support mRNA CDMO customers across Europe and North America
  • Cebina & Charles River Laboratories: Collaboration on the DanubeNeuro project
  • F2G: $100M investment to advance the late-stage development and commercialization of a novel antifungal drug
  • Hello Inside: €1.64M raised to transform women's metabolic health using CGM data
  • IMP: Announcement of the 2024 Birnstiel Awardees
  • Lithoz: 3D-printed ceramic jaw implant innovation
  • MADx: IVDR approval secured for state-of-the-art molecular allergy test by QMD Services
  • ÖGMBT: 2024 Austrian Life Sciences Awards winners revealed
  • Piur Imaging: FDA clearance for its cutting-edge 3D ultrasound technology
  • Takeda: R&D Science Day on November 28 in Vienna – Apply for a meeting slot by October 24

Explore the newsletter for more highlights, upcoming events, and helpful funding opportunities.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.